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Abstract
Pheochromocytoma of the adrenal gland secreting catecholamines is a relatively rare endocrinological cause of secondary arterial hyperten-
sion, usually developing in people aged between 40 and 50, more often in women than in men. Each accidentally diagnosed lesion in 
adrenal glands is an incidentaloma. Incidentalomas are most commonly benign tumours: adenomas, adipomas and angiomas; less often 
they are of a malignant or metastatic character. Establishing the character of the lesion and its hormonal activity is of crucial diagnostic 
significance. Diagnostics of pheochromocytoma covers marking the urine output of catecholamines and their metabolites, as well as marking 
serum amine concentration. Possible treatment of hormonally active lesions includes their surgical removal.
This thesis presents the case of a young female suffering from arterial hypertension for several years, including organ complications, who 
was diagnosed with pheochromocytoma selectively secreting dopamine. (Endokrynol Pol 2012; 63 (5): 391–395)
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Streszczenie
Guz chromochłonny nadnerczy (pheochromocytoma) wydzielający aminy katecholowe jest stosunkowo rzadką endokrynologiczną 
przyczyną wtórnego nadciśnienia tętniczego, rozwijającą się zwykle między 40. a 50. rokiem życia, częściej u kobiet niż u mężczyzn. 
Każda przypadkowo rozpoznana zmiana w nadnerczach to incydentaloma. Incydentaloma to najczęściej nowotwory łagodne — gru-
czolaki, tłuszczaki i naczyniaki; znacznie mniej ma charakter złośliwy lub przerzutowy. Zasadnicze znaczenie diagnostyczne ma 
ustalenie charakteru zmiany i jej aktywności hormonalnej. Diagnostyka guza chromochłonnego obejmuje oznaczenie wydalania 
amin katecholowych i ich metabolitów z moczem oraz stężenia amin w surowicy. Leczeniem z wyboru zmian hormonalnie czynnych 
jest ich chirurgiczne usunięcie.
W niniejszej pracy przedstawiono przypadek młodej kobiety od wielu lat chorującej na nadciśnienie tętnicze z powikłaniami narządowymi, 
u której zdiagnozowano guz chromochłonny wybiórczo wydzielający dopaminę. (Endokrynol Pol 2012; 63 (5): 391–395)
Słowa kluczowe: incydentaloma, guz chromochłonny, nadciśnienie tętnicze
Introduction
Primary arterial hypertension is a common disease, and 
was for many years perceived to be a disease of civilisation. 
In 2005 there were about 1.5 million people suffering from 
arterial hypertension worldwide [1]. The beginning of the 
disease can be deceptive, quite often with a small number 
of symptoms, unlike secondary arterial hypertension, 
which more often includes clinical symptoms characteristic 
for diseases causing this hypertension [2].
Pheochromocytoma, observed in 0.1% of patients suf-
fering from arterial hypertension, is one of the least com-
mon reasons for secondary arterial hypertension [3].
Pheochromocytoma develops from chromaffin cells 
secreting excessive amounts of catecholamines. These 
cells are most commonly located in adrenal glands, 
and less often in other focuses of chromaffin tissue 
[4]. Cells within the adrenal medulla secrete and 
collect noradrenaline, adrenaline and dopamine. 
These amines influence adrenergic receptors in 
organs, and then in the form of metabolites they 
are secreted in urine. All three catecholamines are 
produced from tyrosine over six stages [5]. The first 
stage of this synthesis includes tyrosine hydroxyla-
tion to dihydroxyphenylalanine (DOPA) — this re-
action is performed by tyrosine hydroxylase. DOPA 
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undergoes decarboxylation (reaction executed by 
DOPA-decarboxylase) and creates dopamine. Do-
pamine is transformed into noradrenaline (reaction 
conducted by tyrosine beta-hydroxylase), which 
undergoes methylation creating adrenaline (reaction 
conducted by N-methyltransferase). The crucial stage 
of catecholamine synthesis is the first reaction, as 
amines influence the activity of tyrosine hydroxylase 
based on negative feedback.
Two enzymes inactivate catecholamines: monoam-
ine oxidase (MAO) and catechol-O-methyltransferase 
(COMT). MAO conducts a reaction related to trans-
ferring adrenaline into dihydroxymandelic acid, and 
COMT transfers it into vanillylmandelic acid (con-
stituting 40% of the urine output of catechol amine 
waste products). Adrenaline and noradrenaline can be 
metabolised directly by COMT — as a result of this re-
action we obtain metanephrine and normetanephrine. 
About 5% of catecholamines are secreted with urine in 
an unchanged form.
Pheochromocytoma usually develops in people who 
are between 40 and 50 years old, and in younger peo-
ple it occurs rather in family forms [3]. Typical clinical 
features include paroxysmal or fixed arterial hyperten-
sion, headaches, excessive sweating, palpitations, skin 
paleness (in about 40% of patients), anxiety, muscle 
trembling and orthostatic hypotonia. Atypical symp-
toms may be related to systems other than the circula-
tory system, among others from the alimentary tract 
(stomach aches, constipation, vomiting, acute bowel 
distension) [6]. During pregnancy, pheochromocytoma 
may result in miscarriages or premature placental 
abruption [7, 8]. Sudden secretion of catecholamines 
and attack of clinical symptoms may be caused by 
common stimuli, such as physical effort, abdominal 
pressure, lavish meals, or stress [9].
Basic diagnostic tests related to tumours secret-
ing catecholamines include marking the level of 
fractionated methoxy catecholamines (methoxy 
noradrenaline, methoxy adrenaline) or total meth-
oxy catecholamines (both metabolites together) in 
daily urine output, marking the concentration of 
catecholamines and vanillylmandelic acid [10]. As far 
as blood serum is concerned, the diagnostics include 
marking free methoxy catecholamines and catecho-
lamines. Results of these markings may be false due 
to the activity of various substances: from grocery 
items containing vanillin (e.g. nuts, bananas, black 
tea), drugs (beta-blockers, certain antibiotics, par-
acetamol, antihistamine drugs) and iodic shadowing 
agents used during radiology examinations [11]. As 
for diagnostics, we can also use function tests (cloni-
dine inhibition test, glucagons test). The diagnostic 
value of particular markings is not identical [12–14].
Case report
A 42-year old female was admitted to the Angiology, 
Arterial Hypertension and Diabetology Clinic, with 
a family history of circulatory system diseases (her 
mother died due to myocardial infarction, her father 
died because of cerebral stroke), suffering from arterial 
hypertension with RR increasing up to 200/120 mm Hg 
for the last 20 years. The woman mainly complained of 
the impossibility of obtaining optimal values of arterial 
hypertension despite a regular intake of several drugs 
(ramipril 1 × 10 mg, amilorid with hydrochlorotiaside 
[50/5] 1 × 1 tablet, amlodipine 1 × 10 mg, bisoprolol 
1 × 10 mg, captopril 25 mg in case of increasing pres-
sure values), and she complained about erythema on 
her face. In the past, the patient had suffered two late 
miscarriages, and she had given birth to one child via 
caesarean section (she tolerated the general anaesthesia 
quite well), and for the last two years she had had no 
menstruation.
Several months before hospitalisation, the woman 
underwent an ultrasound examination of her ab-
dominal organs (within the scope of examinations 
after a knee injury), which revealed a nodule in the 
adrenal gland. The result of the above examination was 
confirmed using the CT method, and the nodule with 
smooth contours, and low, fatty densities and measuring 
15 × 18 mm, was qualified as an incidentaloma. In the 
six months between this diagnosis and the time when 
the patient was referred to the Clinic, the symptoms 
had intensified.
Hospitalisation was designed to optimise the hy-
potensive treatment. Physical examination performed 
on the day of admittance revealed alimentary obesity, 
facial redness covering the nose and nasal parts of both 
cheeks, a scar after the caesarean section, contraction 
in the area of the left knee joint, and auscultatory quite 
numerous premature ventricular contractions mak-
ing pairs. Arterial pressure equalled 180/90 mm Hg. 
Due to the patient’s history and ‘pressure resistance’, 
diagnostics covered the secondary reason of arterial 
hypertension. Results of significant biochemical tests 
are shown in Table I.
Echocardiography revealed quite significant ec-
centric hypertrophy of the left ventricular muscle 
(IVSd 16 mm, ED 60 mm) with impairment related 
to the diastolic function, characteristic for relaxa-
tion disorders, and segmental contractility disorders 
covering the anterior and lower wall, with lowering 
of the global systolic function to 50%, most probably 
as the result of hypertensive organ injury. Ultra-
sound examination of carotid arteries revealed single 
arterosclerotic plaques posing no haemodynamic 
significance.
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During hospitalisation, the patient had complex 
hypotensive treatment (metoprolol 100 mg, chinapril 
40 mg, telmisartan 80 mg, hydrochlorotiazyd 25 mg, 
doxazosin 4 mg), which on the one hand caused 
considerable lowering of arterial pressure, but on 
the other hand did not allow it to obtain optimal 
values. Bearing in mind the results of imaging ex-
aminations submitted by the patient (ultrasound of 
abdominal cavity organs and CT), next to the clinical 
image, result of echocardiography, and especially 
the co-existence of significant anomalies in secret-
ing catechol amine metabolites, the diagnostics was 
expanded with MRI of the adrenal glands, which 
confirmed the existence of the nodule in the adrenal 
gland. The whole image supported the diagnosis 
stating pheochromocytoma selectively secreting dopa-
mine. Due to the course of the arterial hypertension, 
especially its ‘resistance’ to administered complex 
pharmacotherapy, and most of all the existence of 
cardiologic complications in the form of contractility 
disorders and significant left ventricular muscle dam-
age, the patient was qualified for scheduled surgical 
removal of the described lesion.
Three months later, the patient underwent lapa-
rotomy, during which the operating personnel removed 
a tumour of 2 cm diameter. The removed material was 
sent for histopathological test, which confirmed the 
diagnosis; the post-operative course was free of compli-
cations. The patient continues to be under the control 
of our centre: two weeks after the procedure, after de-
creasing the amount and doses of hypotensive drugs 
(metoprolol 1 × 50 mg, indapamid 1 × 1.5 mg, ramipril 
1 × 10 mg), pressure values decreased to proper values, 
and the redness on the patient’s skin vanished. After 
a further two months, regular menstruation returned. 
Although the patient still requires the maintenance 
of hypotensive treatment, values of arterial pressure 
remain at an optimal level.
Discussion
This is the case of a young female with a family history 
burdened with circulatory system diseases, who was 
ineffectively treated due to arterial hypertension, and 
this treatment led to organ changes. Because of an ac-
cidental knee injury, the patient was hospitalised, and 
a routine ultrasound examination of the abdominal 
cavity revealed the presence of a nodule in the adre-
nal gland. The result of the examination was verified 
with the CT method and the diagnosis was related to 
incidentaloma. Nonetheless, ‘hypertension resistance’ 
forced the physician in charge of the patient to refer 
the woman to a higher reference clinic, where, based on 
medical history, tests and examinations submitted by the 
patient, she underwent diagnostics towards secondary 
arterial hypertension.
Adrenal gland nodules are usually diagnosed dur-
ing imaging examinations of abdominal cavity organs 
(ultrasound or CT) performed due to various reasons, 
as the so-called screening examinations. Each lesion 
Table I. Results of main laboratory tests
Tabela I. Wyniki głównych badań laboratoryjnych
Test Test result Standard value
Daily urinary output of 3-methoxytyramine Concentration 1,224 μg/d Up to 420 μg/d
Daily urinary output of normetanephrine 506 μg/d Up to 390 μg/d
Daily urinary output of metanephrine 119 μg/d 0–320 μg/d
Daily urinary output of vanillylmandelic acid 3.6 mg/d 0.6–6.0 mg/d
Daily urinary output of 5-hydroxyindolo acetic acid 2.4 mg/d 2.0–9.0 mg/d
Daily urinary output of homovanillic acid 3.7 mg/d 0.6–9.0 mg/d
Daily urinary output of Na+ 248 mmol/d Up to 220 mmol/d
Daily urinary output of K+ 23 mmol/d Up to 125 mmol/d
TSH concentration 0.53 μIU/mL 0.4–4.0 μIU/mL
Daily cortisol profile 8.00: 12.1 μg/dL 
20.00: 5.4 μg/dL
–
RBC 5.6 mln/μL 3.6–5.1 mln/μL
HGB 16.8 g/dL 11.2–15.2 g/dL
TG 228 mg/dL 50–150 mg/dL
RBC — red blood cells; HGB — hemoglobin; TG — triglycerides
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within adrenal glands that is detected by accident is 
known as an incidentaloma [15]. Such lesions are more 
often diagnosed in women than in men, and the number 
of diagnoses increases with age [16, 17].
As far as histopathological examinations are con-
cerned, the majority (about 90%) of incidentalomas 
are benign tumours: adenomas, adipomas and angio-
mas. They less often are of malignant (less than 10%) or 
metastatic (about 3%) character [18]. With CT and MRI 
results, it is possible to state the character of the tumour 
quite precisely. A possibly malignant character of the 
lesion may be indicated by: diameter exceeding 4 cm, 
irregular shape, non-homogenous structure, uneven 
outlines and thick, non-homogenous circumferential 
area, which is amplified after administering contrast, 
as well as dynamics of rinsing the contrasting agent 
(density > 10 Hounsfield Units [HU] and slow rinsing 
of the contrasting agent suggest a malignant character 
of a lesion) [19]. These features were not observed in 
examinations of our patient, which perhaps decreased 
the vigilance of the physician, who treated the patient 
for hypertension.
Biochemical diagnostics of pheochromocytoma cover 
marking catecholamines in serum and their derivatives 
in urine. Unfortunately, not all performed markings 
are of equal diagnostic value [20]. In the case of the 
described patient, a standard panel of biochemical 
tests in daily urine output was performed, where only 
concentration of 3-methoxytyramine was significantly 
exceeded, and concentration of normetanephrine was 
only slightly exceeded. These results show that, in the 
case of this patient, arterial hypertension was caused by 
an excessive amount of catecholamines. Such significant 
predominance of 3-methoxytyramine concentration 
over other metabolites of catecholamines indicated that 
the organism of the patient mainly produced excessive 
amounts of dopamine, and 3-methoxytyramine is the 
waste product of the above.
Another issue which was supposed to be taken into 
consideration was the source of dopamine. Assuming 
the most obvious solution, it was admitted that it was 
this change in the adrenal gland, which was hormonally 
active and secretes excessive amount of dopamine. Ac-
tive hormonal changes, as well as quickly increasing 
lesions, constitute the recommendation for surgical 
procedure [21, 22]. Low-invasive surgery is a preferred 
treatment of functioning and non-functioning adrenal 
tumours [23].
The tumour was removed, a histopathological test 
confirmed the diagnosis, and the result of an opera-
tion supported the assumption: proper values of ar-
terial pressure were obtained with the use of a small 
amount of hypotensive drugs; other ailments were 
also relieved, such as menstruation disorders. It can 
be assumed that obstetric setbacks in the patient’s 
history could be related to the basic disease; however, 
there is no direct proof.
In conclusion, it is worth noting that functional 
disorders of the circulatory system, especially ones 
resulting from environmental and social stress, quite 
often resemble symptoms of a chromaffin tumour. 
In reality, patients, and especially women referred 
to undergo diagnostics related to hypertension, 
most commonly complain of palpitations, anxiety, 
suddenly increasing values of arterial pressure and 
‘resistance’ to administered drugs. Such patients 
constitute about 50% of patients referred to undergo 
diagnostics with initial diagnosis stating “suspicion 
of chromaffin tumour”.
This extremely rare secondary form of arterial hy-
pertension is not only related to subjective sensation of 
hypercatecholaminemia, but it is also usually connected 
to somatic organ changes reflecting a severe course of 
the hypertensive disease.
Patients with negative results of biochemical tests 
and imaging examinations are candidates to be diag-
nosed with initial arterial hypertension, whereas the 
co-existence of pathologies described by a radiology 
specialist as an incidentaloma should always provoke 
suspicion and should be the cause of expanding the 
diagnostics. Krawczyk et al. [24] have also suggested 
that each case of pheochromocytoma requires a DNA 
analysis because of a significant genetic diathesis for 
these tumours.
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